treating richter’s transformation with venetoclax, obinutuzumab and atezolizumab
Published 2 years ago • 369 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:47
treatment of richter’s transformation: recent insights
-
1:12
novel treatment strategies for richter’s transformation
-
1:32
how to treat richter’s transformation
-
0:54
a research update in richter's transformation from ash 2023
-
1:03
strategies for treating richter’s transformation in cll: checkpoint inhibitors and venetoclax
-
1:08
richter’s transformation: the need for more therapeutic agents in this space
-
1:49
the management of richter's transformation: current approaches and future outlooks
-
2:57
latest advances in car-t therapy for cll and richter’s transformation
-
6:50
venetoclax retreatment for cll
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
1:56
stellar: genomic sequencing of ctdna reveals additional driver mutations in richter's transformation
-
2:58
var-cel shows promise for the treatment of cll and richter's transformation
-
1:24
investigating the biology of richter’s transformation
-
3:44
the safety and efficacy of venetoclax-based treatment for patients with richter's syndrome
-
3:54
richter's syndrome: clinical needs and treatment choices
-
1:15
promising agents emerging for richter’s transformation
-
4:09
advances & challenges in the diagnosis and treatment of richter’s syndrome
-
1:54
nivolumab ibrutinib for patients with richter’s transformation
-
1:04
potential concerns with ventoclax and richter's transformation
-
1:46
acalabrutinib for the treatment of richter's transformation and patients with ibrutinib intolerance
-
3:28
the use of anti-cd19 car-t therapy for richter’s transformation